[慢性肾脏病合并多发性骨髓瘤患者自体移植后肾功能部分恢复] - Suppr

[Partial recovery of kidney function for an autologous transplant in a patient with chronic kidney disease and multiple myeloma].

作者信息

de Alarcón Jiménez R M, Roca Meroño S, Alvarez Fernández G M, García Hernández M A, Navarro Parreño M J, Jimeno Griñó C, Zarco Pedrinaci E, Molina Núñez M

出版信息

Nefrologia. 2011;31(2):238-40. doi: 10.3265/Nefrologia.pre2010.Aug.10496.

DOI:10.3265/Nefrologia.pre2010.Aug.10496

PMID:21461027

Abstract

摘要

相似文献

[Partial recovery of kidney function for an autologous transplant in a patient with chronic kidney disease and multiple myeloma].

Nefrologia. 2011;31(2):238-40. doi: 10.3265/Nefrologia.pre2010.Aug.10496.

DKK1 correlates with response and predicts rapid relapse after autologous stem cell transplantation in multiple myeloma.

Eur J Haematol. 2010 Mar;84(3):276-7. doi: 10.1111/j.1600-0609.2009.01372.x. Epub 2009 Nov 5.

Mantle cell lymphoma arising in a multiple myeloma patient responding to lenalidomide.

Leuk Res. 2010 Jul;34(7):e178-80. doi: 10.1016/j.leukres.2010.01.002. Epub 2010 Jan 15.

Long-term remission of paraprotein-induced immunotactoid glomerulopathy after high-dose therapy and autologous blood stem cell transplantation.

Ann Hematol. 2007 Dec;86(12):927-30. doi: 10.1007/s00277-007-0330-6. Epub 2007 Jun 29.

[Hematopoietic stem cell transplantation for multiple myeloma].

Rinsho Ketsueki. 2009 Oct;50(10):1420-6.

[Improved prognosis in light chain nephropathy due to multiple myeloma].

Ugeskr Laeger. 2012 Apr 23;174(17):1159-60.

Achieving an early myeloma response in patients with kidney impairment.

Adv Chronic Kidney Dis. 2012 Sep;19(5):303-11. doi: 10.1053/j.ackd.2012.07.005.

A phase I/II trial combining high-dose melphalan and autologous transplant with bortezomib for multiple myeloma: a dose- and schedule-finding study.

Clin Cancer Res. 2010 Oct 15;16(20):5079-86. doi: 10.1158/1078-0432.CCR-10-1662. Epub 2010 Aug 25.

Lambda light chain myeloma with oliguric cast nephropathy and remission with bortezomib, doxorubicin and dexamethasone.

JNMA J Nepal Med Assoc. 2012 Oct-Dec;52(188):192-5.

Bortezomib as induction before autologous transplantation, followed by lenalidomide as consolidation-maintenance in untreated multiple myeloma patients.

J Clin Oncol. 2010 Feb 10;28(5):800-7. doi: 10.1200/JCO.2009.22.7561. Epub 2010 Jan 4.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

[Partial recovery of kidney function for an autologous transplant in a patient with chronic kidney disease and multiple myeloma].

Nefrologia. 2011;31(2):238-40. doi: 10.3265/Nefrologia.pre2010.Aug.10496.

DKK1 correlates with response and predicts rapid relapse after autologous stem cell transplantation in multiple myeloma.

Eur J Haematol. 2010 Mar;84(3):276-7. doi: 10.1111/j.1600-0609.2009.01372.x. Epub 2009 Nov 5.

Mantle cell lymphoma arising in a multiple myeloma patient responding to lenalidomide.

Leuk Res. 2010 Jul;34(7):e178-80. doi: 10.1016/j.leukres.2010.01.002. Epub 2010 Jan 15.

Long-term remission of paraprotein-induced immunotactoid glomerulopathy after high-dose therapy and autologous blood stem cell transplantation.

Ann Hematol. 2007 Dec;86(12):927-30. doi: 10.1007/s00277-007-0330-6. Epub 2007 Jun 29.

[Hematopoietic stem cell transplantation for multiple myeloma].

Rinsho Ketsueki. 2009 Oct;50(10):1420-6.

[Improved prognosis in light chain nephropathy due to multiple myeloma].

Ugeskr Laeger. 2012 Apr 23;174(17):1159-60.

Achieving an early myeloma response in patients with kidney impairment.

Adv Chronic Kidney Dis. 2012 Sep;19(5):303-11. doi: 10.1053/j.ackd.2012.07.005.

A phase I/II trial combining high-dose melphalan and autologous transplant with bortezomib for multiple myeloma: a dose- and schedule-finding study.

Clin Cancer Res. 2010 Oct 15;16(20):5079-86. doi: 10.1158/1078-0432.CCR-10-1662. Epub 2010 Aug 25.

Lambda light chain myeloma with oliguric cast nephropathy and remission with bortezomib, doxorubicin and dexamethasone.

JNMA J Nepal Med Assoc. 2012 Oct-Dec;52(188):192-5.

Bortezomib as induction before autologous transplantation, followed by lenalidomide as consolidation-maintenance in untreated multiple myeloma patients.

J Clin Oncol. 2010 Feb 10;28(5):800-7. doi: 10.1200/JCO.2009.22.7561. Epub 2010 Jan 4.

[Partial recovery of kidney function for an autologous transplant in a patient with chronic kidney disease and multiple myeloma].

作者信息

de Alarcón Jiménez R M, Roca Meroño S, Alvarez Fernández G M, García Hernández M A, Navarro Parreño M J, Jimeno Griñó C, Zarco Pedrinaci E, Molina Núñez M

出版信息

Nefrologia. 2011;31(2):238-40. doi: 10.3265/Nefrologia.pre2010.Aug.10496.

DOI:10.3265/Nefrologia.pre2010.Aug.10496

PMID:21461027

Abstract

摘要

[Partial recovery of kidney function for an autologous transplant in a patient with chronic kidney disease and multiple myeloma].

作者信息

出版信息

相似文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

[Partial recovery of kidney function for an autologous transplant in a patient with chronic kidney disease and multiple myeloma].

作者信息

出版信息